Tokyo, Nov. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063337) titled 'Observational Study on the Efficacy and Safety of Ultrahypofractionated Whole-Breast Irradiation after Breast-Conserving Surgery' on Nov. 16.
Study Type:
Observational
Primary Sponsor:
Institute - St. Luke's International University, St. Luke's International Hospital
Condition:
Condition - Breast Cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To prospectively investigate the outcomes of ultrahypofractionated whole-breast irradiation in patients following breast-conserving surgery and to clarify its efficacy and safety.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 20
years-old
Gender - Female
Key inclusion criteria - Patients with breast cancer who have undergone breast-conserving surgery at our institution and are deemed candidates for whole-breast irradiation without indication for postoperative regional nodal irradiation.
Key exclusion criteria - Patients currently undergoing treatment for another malignancy.
Target Size - 120
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2026 Year 10 Month 19 Day
Date of IRB - 2026 Year 10 Month 19 Day
Anticipated trial start date - 2026 Year 11 Month 16 Day
Last follow-up date - 2031 Year 07 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072494
Disclaimer: Curated by HT Syndication.